SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
01-Feb-24 6:00 PM View: | PharmAthene, Inc. (ALT) | 31-Jan-24 | Grant | 4,621 | $2.69 | $12,430.50 | 11% 40.39K to 45.01K | |
01-Feb-24 6:00 PM View: | PharmAthene, Inc. (ALT) | 30-Jan-24 | Payment of Exercise | 2,175 | $9.80 | $21,315.00 | (5%) 42.57K to 40.39K | |
01-Feb-24 6:00 PM View: | PharmAthene, Inc. (ALT) | 30-Jan-24 | Option Exercise | 9,275 | -- | -- | 28% 33.29K to 42.57K | |
02-Jan-24 6:00 PM View: | PharmAthene, Inc. (ALT) | 29-Dec-23 | Payment of Exercise | 3,044 | $11.25 | $34,245.00 | (8%) 36.34K to 33.29K | |
02-Jan-24 6:00 PM View: | PharmAthene, Inc. (ALT) | 29-Dec-23 | Option Exercise | 12,500 | -- | -- | 52% 23.84K to 36.34K | |
02-Aug-23 5:51 PM View: | PharmAthene, Inc. (ALT) | 31-Jul-23 | Grant | 1,825 | $2.81 | $5,128.25 | 8% 22.01K to 23.84K | |
24-Mar-23 8:54 PM View: | PharmAthene, Inc. (ALT) | 24-Mar-23 | Private Purchase | 10,000 | $4.31 | $43,140.00 | 83% 12.01K to 22.01K | |
02-Feb-23 5:09 PM View: | PharmAthene, Inc. (ALT) | 31-Jan-23 | Grant | 1,172 | $10.21 | $11,964.40 | 11% 10.84K to 12.01K | |
03-Jan-23 5:59 PM View: | PharmAthene, Inc. (ALT) | 31-Dec-22 | Payment of Exercise | 3,028 | $16.45 | $49,810.60 | (22%) 13.87K to 10.84K | |
03-Jan-23 5:59 PM View: | PharmAthene, Inc. (ALT) | 31-Dec-22 | Option Exercise | 12,500 | -- | -- | 915% 1.37K to 13.87K | |
03-Aug-22 4:05 PM View: | PharmAthene, Inc. (ALT) | 31-Jul-22 | Grant | 1,366 | $6.86 | $9,370.76 | 100% 0 to 1.37K | |
05-Apr-21 7:15 PM View: | Aytu Biopharma, Inc (AYTU) | 31-Mar-21 | Grant | 55,000 | -- | -- | 400% 13.73K to 68.73K | |
19-Mar-21 5:04 PM View: | Neos Therapeutics, Inc. (NEOS) | 19-Mar-21 | Disposition | 126,245 | -- | -- | (100%) 126.25K to 0 | |
16-Mar-21 8:49 AM View: | Neos Therapeutics, Inc. (NEOS) | 02-Mar-21 | Payment of Exercise | 14,825 | $0.84 | $12,512.30 | (11%) 141.07K to 126.25K | (38%) |
16-Mar-21 8:49 AM View: | Neos Therapeutics, Inc. (NEOS) | 01-Mar-21 | Payment of Exercise | 1,390 | $0.88 | $1,227.37 | (< 1%) 142.46K to 141.07K | (32%) |
04-Mar-20 5:22 PM View: | Neos Therapeutics, Inc. (NEOS) | 02-Mar-20 | Grant | 100,000 | -- | -- | (100%) (-100.0K) to 0 | |
13-Dec-18 4:08 PM View: | Neos Therapeutics, Inc. (NEOS) | 12-Dec-18 | Market Purchase | 5,000 | $2.16 | $10,819.50 | 13% 37.46K to 42.46K | (44%) |
05-Mar-18 5:14 PM View: | Neos Therapeutics, Inc. (NEOS) | 01-Mar-18 | Grant | 18,750 | -- | -- | 100% 18.71K to 37.46K | |
02-May-17 9:09 PM View: | Neos Therapeutics, Inc. (NEOS) | 01-May-17 | Grant | 15,000 | -- | -- | 404% 3.71K to 18.71K | |
25-Aug-16 4:34 PM View: | Neos Therapeutics, Inc. (NEOS) | 25-Aug-16 | Market Purchase | 3,710 | $6.82 | $25,283.70 | 100% 0 to 3.71K | (82%) |